The Technical Analyst
Calyxt Inc [CLXT]
Exchange: NASDAQ Sector: Consumer Defensive Industry: Packaged Foods
Calyxt Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
5.53% $6.30
America/New_York / 31 mai 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 31.33 mill |
| EPS: | -3.83 |
| P/E: | -1.645 |
| Earnings Date: | Aug 02, 2023 |
| SharesOutstanding: | 4.97 mill |
| Avg Daily Volume: | 0.0225 mill |
| RATING 2023-08-02 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | ||||
| Gr.Profit | n/a | n/a | ||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.645 | sector: PE 9.79 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.06x |
| Company: PE -1.645 | industry: PE 29.33 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 17.00 - 22.03 ( +/- 12.89%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-29 | Riggs Rory B | Buy | 1 500 000 | Class A Common Stock |
| 2023-12-29 | Riggs Rory B | Buy | 1 505 967 | Class B Common Stock |
| 2023-12-29 | Riggs Rory B | Buy | 1 505 967 | Cibus Common Units |
| 2023-12-29 | Riggs Rory B | Sell | 1 500 000 | Class B Common Stock |
| 2023-12-29 | Riggs Rory B | Sell | 1 500 000 | Cibus Common Units |
| INSIDER POWER |
|---|
| 64.25 |
| Last 90 transactions |
| Buy: 25 451 526 | Sell: 4 874 467 |
Forecast:
01:40 - $20.61
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $6.30 (5.53% ) |
| Volume | 0.254 mill |
| Avg. Vol. | 0.0225 mill |
| % of Avg. Vol | 1 128.38 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CLXT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CLXT
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
Latest Press Releases
2023-01-17 06:30:00 - Press Release
Calyxt And Cibus Announce Definitive Merger Agreement To Create Industry-leading Precision Gene Editing And Trait Licensing Company
– the merger will bring together the technology platforms and facilities of two pioneering companies to create a leader in precision gene editing focused on driving sustainable agriculture and the availability of renewable low-carbon ingredients – – upon closure of the merger, rory riggs, cibus co-founder, will become c hief executive officer and chairman of the combined company and the cibus leadership team will lead the new organization – roseville, minn. and san diego , jan. 17, 2023 /prnewswire/ -- calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company, and cibus, a leader in precision gene editing in agriculture, today announced that both companies have entered into a definitive merger agreement under which calyxt and cibus will merge in an all-stock transaction.
2022-07-28 07:00:00 - Press Release
Calyxt To Present At The Canaccord Genuity 42nd Annual Growth Conference
Roseville, minn. , july 28, 2022 /prnewswire/ -- calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company, today announced that michael a.
2022-07-21 07:00:00 - Press Release
Calyxt To Host Second Quarter 2022 Financial Results Conference Call And Webcast On Thursday, August 4, 2022, At 4:30 P.m. Eastern Time
Roseville, minn. , july 21, 2022 /prnewswire/ -- calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company, will host a conference call and webcast on thursday, august 4, 2022, at 4:30 p.m.
2022-04-21 07:08:00 - Press Release
Calyxt To Host First Quarter 2022 Financial Results Conference Call And Webcast On Thursday, May 5, 2022, At 4:30 P.m. Eastern Time
Roseville, minn. , april 21, 2022 /prnewswire/ -- calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company, will host a conference call and webcast on thursday, may 5, 2022, at 4:30 p.m.
2022-02-24 07:00:00 - Press Release
Calyxt To Host Fourth Quarter And Full Year 2021 Financial Results Conference Call On Thursday, March 3, 2022, At 4:30 P.m. Eastern Time
Roseville, minn., feb. 24, 2022 /prnewswire/ -- calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company, will hold a conference call on thursday, march 3, 2022, at 4:30 p.m.
Latest News
2023-01-18 06:00:00 - PennyStocks
What Penny Stocks Trends Can Help You Profit in 2023?
How to make money with penny stocks in 2023 The post What Penny Stocks Trends Can Help You Profit in 2023? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-01-17 09:24:14 - PennyStocks
5 Penny Stocks To Watch After Big News This Week
Penny stocks to watch with news that are turning heads in the stock market this week. The post 5 Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-01-17 08:10:29 - InvestorPlace
Why Is Calyxt (CLXT) Stock Up 140% Today?
Calyxt (NASDAQ: CLXT ) stock is rocketing higher on Tuesday after the company signed a merger agreement with Cibus Global. Calyxt and Cibus Global both operate in the agriculture-based gene editing sector.
2022-11-06 11:07:10 - Seeking Alpha
Calyxt, Inc. (CLXT) Q3 2022 Earnings Call Transcript
Calyxt, Inc. (NASDAQ:CLXT ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants William Koschak - CFO Michael Carr - President and CEO Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Calyxt Third Quarter 2022 Financial Results and Corporate Update Conference Call and Webcast.
2022-11-03 18:48:30 - Zacks Investment Research
Calyxt (CLXT) Reports Q3 Loss, Misses Revenue Estimates
Calyxt (CLXT) delivered earnings and revenue surprises of 13.33% and 86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-08-07 13:45:05 - Seeking Alpha
Calyxt, Inc. (CLXT) CEO Michael Carr on Q2 2022 Results - Earnings Call Transcript
Calyxt, Inc. (NASDAQ:CLXT ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH Capital Partners Operator Good afternoon, ladies and gentlemen.
2022-07-28 07:00:00 - PRNewsWire
Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference
ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A.
2022-07-21 07:00:00 - PRNewsWire
Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time
ROSEVILLE, Minn. , July 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at 4:30 p.m.
2022-05-08 03:07:11 - Seeking Alpha
Calyxt, Inc. (CLXT) CEO Michael Carr on Q1 2022 Results - Earnings Call Transcript
Calyxt, Inc. (NASDAQ:CLXT ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Bill Koschak - Chief Financial Officer Michael Carr - President and Chief Executive Officer Conference Call Participants Bobby Burleson - Canaccord Amit Dayal - H.C. Wainwright Brian Wright - ROTH Capital Partners Operator Good afternoon, ladies and gentlemen.
2022-04-21 07:08:00 - PRNewsWire
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
ROSEVILLE, Minn. , April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, May 5, 2022, at 4:30 p.m.